Read More Pharma Industry News Trevi Therapeutics announces positive results for Haduvio in Phase 2b CORAL study Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, has reported a positive outcome from the planned sample size re-estimation… byPallavi MadhirajuDecember 12, 2024